As the chemical, pharmaceutical and biotech industries continue to outsource core activities, companies find themselves with more and more idle and surplus manufacturing machinery, laboratory instrumentation, and technology equipment.
There have always been equipment dealers buying up these surplus assets for pennies on the dollar and selling them to universities and small contract manufacturers. But in recent years, global manufacturers have been discovering the hidden value in idle assets found throughout their enterprises and are now taking a much more revolutionary approach, focusing on boosting their efficiency and their bottom line by proactively managing their total asset base.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.